Moleculin Biotech, Inc. Interest Expense
Moleculin Biotech, Inc. (MBRX) reported Interest Expense of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2018-03-28
- Moleculin Biotech, Inc. interest expense for the quarter ending 2017-12-31 was -$2.00K, a 133.33% decline year-over-year.
- Moleculin Biotech, Inc. interest expense for the quarter ending 2017-09-30 was $1.00K, a 90.00% decline year-over-year.
- Moleculin Biotech, Inc. interest expense for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Moleculin Biotech, Inc. interest expense for the quarter ending 2017-03-31 was $1.00K, a 90.91% decline year-over-year.
- Moleculin Biotech, Inc. interest expense for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Moleculin Biotech, Inc. interest expense for fiscal 2016 was $43.00K.
| Period end | Interest Expense 2 month | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 5 month | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$1.00K derived: sum of 2 quarters · filed 2018-03-28 | -$1.00K derived: sum of 3 quarters · filed 2018-03-28 | $0.00 10-K · filed 2018-03-28 | ||||||
| 2017-09-30 | $1.00K 10-Q · filed 2017-11-13 | $1.00K derived: sum of 2 quarters · filed 2017-11-13 | $2.00K 10-Q · filed 2017-11-13 | $8.00K derived: sum of 4 quarters · filed 2018-03-28 | ||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | $1.00K 10-Q · filed 2017-08-11 | $7.00K derived: sum of 3 quarters · filed 2018-03-28 | $17.00K derived: sum of 4 quarters · filed 2018-03-28 | ||||||
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-12 | $7.00K derived: sum of 2 quarters · filed 2018-03-28 | $17.00K derived: sum of 3 quarters · filed 2018-03-28 | $32.00K derived: sum of 4 quarters · filed 2018-03-28 | ||||||
| 2016-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $16.00K derived: sum of 2 quarters · filed 2018-03-28 | $31.00K derived: sum of 3 quarters · filed 2018-03-28 | $43.00K 10-K · filed 2018-03-28 | $43.21K 10-K · filed 2017-04-03 | |||||
| 2016-09-30 | $10.00K 10-Q · filed 2017-11-13 | $10.40K 10-Q · filed 2016-11-21 | $25.00K derived: sum of 2 quarters · filed 2017-11-13 | $37.00K 10-Q · filed 2017-11-13 | $37.31K 10-Q · filed 2016-11-21 | |||||
| 2016-06-30 | $15.00K 10-Q · filed 2017-08-11 | $15.23K 10-Q · filed 2016-08-15 | $27.00K 10-Q · filed 2017-08-11 | $26.91K 10-Q · filed 2016-08-15 | ||||||
| 2016-03-31 | $11.00K 10-Q · filed 2017-05-12 | $11.67K 10-Q · filed 2016-06-16 | ||||||||
| 2015-12-31 | $10.13K 10-K · filed 2017-04-03 | |||||||||
| 2015-09-30 | $1.56K 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |